about
Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facilityDeclining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, CanadaPublic crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder.The role of safer injection facilities in the response to HIV/AIDS among injection drug users.The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges.Gang involvement among street-involved youth in a Canadian setting: a gender-based analysis.Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.Socioeconomic marginalisation in the structural production of vulnerability to violence among people who use illicit drugs.Income generating activities of people who inject drugs.Modelling crack cocaine use trends over 10 years in a Canadian setting.High Prevalence of Assisted Injection Among Street-Involved Youth in a Canadian Setting.Aboriginal street-involved youth experience elevated risk of incarceration.Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada.The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugsEviction and loss of income assistance among street-involved youth in Canada.Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs.Public injecting among a cohort of injecting drug users in Vancouver, Canada.Non-medical prescription opioid use among youth: Gaining perspective from decades of previous drug use epidemics.Canada's 2003 renewed drug strategy--an evidence-based reviewHepatitis C cascade of care among people who inject drugs in Vancouver, CanadaDeveloping Canada's research base for harm reduction and health equity approaches to HIV prevention and treatmentCanada's new federal ‘National Anti-Drug Strategy’: An informal audit of reported funding allocationLaw enforcement and Australia's 2001 heroin shortage: Evaluating the evidenceStreet-involved youth engaged in sex work at increased risk of syringe sharingPerceived Devaluation among a Cohort of Street-Involved Youth in Vancouver, CanadaMoving into an urban drug scene among people who use drugs in Vancouver, Canada: Latent class growth analysisOpioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysisTrajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: growth mixture modeling using data from prospective cohort studiesCoercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, CanadaCharacterising the association between positive hepatitis C virus antibody and pain among people who inject drugsImpact of migration from an illicit drug scene on hospital outcomes among people who use illicit drugs in Vancouver, Canada
P50
Q24649575-90344F7F-E9AD-49C8-A729-21D7ED1994A4Q33711886-1012E7A0-B433-4824-92C7-AB12E3BAE82EQ34415820-7011077C-505D-4485-B96D-5005AF2F1389Q34626103-6BC08BF6-2AB0-4FA0-ACEA-A58AA1510DA7Q34764625-A9943C7E-D4CC-49F6-A325-E759E261C459Q34954262-CC34C6D7-DAE3-449B-BD4D-875AA4EE1D63Q35009532-83CC39A7-E43D-4BCC-93F3-BC2985200AE6Q35703205-C02B93D4-3392-4A20-8479-0A9CF7D16290Q35738450-7057485F-A590-419E-BFD7-47298C190690Q36101111-D9282861-48A4-46BF-AA9F-D5A70FCFA389Q36277065-0F3D74C0-ED40-4395-99A4-DDB1C906EF94Q36348341-720FC68D-C7BD-4100-BBBD-D6BB0FE16D00Q36396036-CEAFB83B-0C21-41E0-941F-3DA2D9E4F51AQ36922133-D5783C96-0D5E-451C-9E5C-A1F96967458AQ37062964-A8D3B5DA-9827-43AA-9653-ED76E9E3334CQ37272351-C396E956-2F3D-4A4B-B357-2458B41DBEC6Q37394050-9CAF1C6F-90A9-4A04-958C-BB822D496161Q39853391-523BB0F2-16B7-47EB-B653-3344EBECEC0CQ40702420-0C113E87-5613-4B20-BFB2-8E87ED5795D9Q56912624-F2A25848-0EFC-44EF-A530-1834472EF8F5Q57050771-55EB92EE-F04B-4136-B69F-F375DDA8EDEBQ57153779-5D839A98-0E06-4E0B-B965-C71E8987A403Q58797483-C86D7B7F-F123-4C59-A56B-68778BFE2591Q58797490-A97FC5BD-5B3B-483C-B728-97BDEE129F90Q89589316-C747D95D-AF3E-4726-9760-AFC5B3A681A8Q90334914-A41E928D-A601-4E80-8EC4-65493F0A03A9Q91279886-8E20FD3F-1E5B-4FBC-9811-B516DC449879Q91464404-F4E1F870-D7AE-4323-8B4F-FCDF9EB1AC60Q92062202-C6A08BDE-F4A9-495B-88B3-C3537AA9367CQ92398939-4254CDA4-B865-47A0-8E6B-B8D3E070F9D0Q92659150-C2505634-A2B7-4EB1-A669-616930FE9036Q96109884-954138E0-B252-4169-8409-0DF0D78F5407
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kora DeBeck
@ast
Kora DeBeck
@en
Kora DeBeck
@es
Kora DeBeck
@nl
Kora DeBeck
@sl
type
label
Kora DeBeck
@ast
Kora DeBeck
@en
Kora DeBeck
@es
Kora DeBeck
@nl
Kora DeBeck
@sl
prefLabel
Kora DeBeck
@ast
Kora DeBeck
@en
Kora DeBeck
@es
Kora DeBeck
@nl
Kora DeBeck
@sl
P106
P31
P496
0000-0003-2045-1653